Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors

PURPOSE: The use of anthracycline chemotherapy is associated with heart failure (HF) among survivors of non-Hodgkin lymphoma (NHL). We aimed to understand the contribution of preexisting cardiovascular risk factors to HF risk among NHL survivors. METHODS: Using Danish registries, we identified adult...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Salz, Talya, Zabor, Emily C., de Nully Brown, Peter, Dalton, Susanne Oksberg, Raghunathan, Nirupa J., Matasar, Matthew J., Steingart, Richard, Vickers, Andrew J., Svenssen Munksgaard, Peter, Oeffinger, Kevin C., Johansen, Christoffer
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2017
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5707207/
https://ncbi.nlm.nih.gov/pubmed/28922087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.72.4211
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky